T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Innospec
IOSP
$2.12B
| $2.32M | ﹤0.01% |
31,826
+3,443
| +12% | +$268K |
|
1752
Capri Holdings
CPRI
$1.88B
| $2.32M | ﹤0.01% |
131,730
+22,701
| +21% | +$480K |
|
1753
Matthews International
MATW
$900M
| $2.32M | ﹤0.01% |
89,893
+8,766
| +11% | +$230K |
|
1754
Dentsply Sirona
XRAY
$2.7B
| $2.32M | ﹤0.01% |
199,965
+16,292
| +9% | +$203K |
|
1755
1st Source
SRCE
$2.18B
| $2.31M | ﹤0.01% |
33,349
+2,840
| +9% | +$191K |
|
1756
BOK Financial
BOKF
$8.65B
| $2.3M | ﹤0.01% |
17,975
-486
| -3% | -$62.4K |
|
1757
Garrett Motion
GTX
$5.6B
| $2.3M | ﹤0.01% |
126,523
+36,463
| +40% | +$680K |
|
1758
James River Group Holdings
JRVR
$221M
| $2.3M | ﹤0.01% |
364,577
-418,681
| -53% | -$2.75M |
|
1759
First Commonwealth Financial
FCF
$2.17B
| $2.29M | ﹤0.01% |
130,410
+14,895
| +13% | +$262K |
|
|
MPLT
1760
MapLight Therapeutics
MPLT
$558M
| $2.29M | ﹤0.01% |
+112,708
| New | +$2.02M |
|
1761
Equinor
EQNR
$90.9B
| $2.29M | ﹤0.01% |
+54,191
| New | +$1.63M |
|
|
GRAL
1762
GRAIL Inc
GRAL
$2.76B
| $2.29M | ﹤0.01% |
44,215
-166,553
| -79% | -$12.9M |
|
1763
Stock Yards Bancorp
SYBT
$2.52B
| $2.29M | ﹤0.01% |
34,460
+4,457
| +15% | +$297K |
|
1764
Ashland
ASH
$3.11B
| $2.28M | ﹤0.01% |
41,056
+5,240
| +15% | +$310K |
|
1765
Tenable Holdings
TENB
$3.46B
| $2.28M | ﹤0.01% |
134,545
+16,105
| +14% | +$338K |
|
1766
Atkore
ATKR
$2.62B
| $2.27M | ﹤0.01% |
38,607
+5,824
| +18% | +$379K |
|
1767
Amneal Pharmaceuticals
AMRX
$5.99B
| $2.27M | ﹤0.01% |
182,941
+38,237
| +26% | +$513K |
|
1768
ImmunityBio
IBRX
$7.3B
| $2.26M | ﹤0.01% |
294,831
+136,589
| +86% | +$935K |
|
1769
Rogers Corp
ROG
$2.13B
| $2.26M | ﹤0.01% |
21,013
+3,618
| +21% | +$372K |
|
1770
Peoples Bancorp
PEBO
$1.52B
| $2.25M | ﹤0.01% |
68,415
+6,457
| +10% | +$208K |
|
1771
Sarepta Therapeutics
SRPT
$1.63B
| $2.25M | ﹤0.01% |
103,287
+13,249
| +15% | +$256K |
|
1772
Kaiser Aluminum
KALU
$2.65B
| $2.24M | ﹤0.01% |
18,613
+2,901
| +18% | +$367K |
|
1773
Northwest Bancshares
NWBI
$2.33B
| $2.24M | ﹤0.01% |
176,163
+24,214
| +16% | +$305K |
|
1774
City Holding Co
CHCO
$2.04B
| $2.23M | ﹤0.01% |
18,676
+2,254
| +14% | +$275K |
|
1775
S&T Bancorp
STBA
$1.92B
| $2.23M | ﹤0.01% |
53,264
+8,469
| +19% | +$354K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.